4//SEC Filing
Ajer Jeffrey Robert 4
Accession 0000950170-25-093102
CIK 0001590750other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:43 PM ET
Size
5.6 KB
Accession
0000950170-25-093102
Insider Transaction Report
Form 4
Ajer Jeffrey Robert
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-07-01+21,000→ 21,000 totalExercise: $14.47Exp: 2035-07-01→ Common Stock (21,000 underlying)
Footnotes (1)
- [F1]The option vests in full upon the earlier to occur of (i) July 1, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer.
Documents
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001557533
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:43 PM ET
- Size
- 5.6 KB